Gagnon Robert E.
Opus Genetics, Inc. · Chief Financial Officer
Gagnon Robert E. is listed in public filings as officer: Chief Financial Officer. This Gagnon Robert E. insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Opus Genetics, Inc. (IRD), Verastem, Inc. (VSTM), Harvard Bioscience, Inc. (HBIO), Bone Biologics Corporation (BBLGW), and Bone Biologics Corporation (BBLG). Investors use Gagnon Robert E.'s insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| $2.6k283 shares | SellDec 16, 2025 | $9.14 | -- | |
| $2.8k281 shares | SellSep 16, 2025 | $9.99 | -- | |
| $1.6k284 shares | SellJun 16, 2025 | $5.65 | -- | |
| $2.0k284 shares | SellMar 17, 2025 | $6.95 | -- | |
| $568130 shares | SellDec 19, 2024 | $4.37 | -- | |
| $1.3k285 shares | SellDec 16, 2024 | $4.54 | -- | |
| $365131 shares | SellSep 19, 2024 | $2.79 | -- | |
| $804287 shares | SellSep 16, 2024 | $2.80 | -- | |
| $421131 shares | SellJun 20, 2024 | $3.21 | -- | |
| $988283 shares | SellJun 17, 2024 | $3.49 | -- |